Dr. Mary Claire Haver

No one's making money by selling oral estradiol, okay?

You need a designer estrogen.

You need a designer progestin.

That is where that money from Big Pharma is going into, is in these designer drugs, which I'm happy to have the research, but they're really esoteric and really, really not needed by the majority of patients.

They can do plain...

estradiol and plain progesterone, which are so inexpensive that no one is going to make money.

So there's no pharma money, not really coming from that level.

Third is private entities.

And we are seeing women who are coming into a lot of money starting to fund these studies.

So when we look at the Melinda Gates Foundation, I have to give her props.

She is

donating money to study women's health in a way that's never been done before.

Okay.

So anyone listening out there who is a philanthropist and you want to go look for the studies being done in women, usually by women for women, there are out there.

There's so many great ways.

Rachel Rubin's running several studies, you know, different universities are running studies.

Stanford's got a great menopause program.

A lot of the bigger universities are really opening up the floodgates and

for menopause research in really clinically significant ways.

And those kind of things need to be funded.